Dr Adler First in the Treasure Toast to Inject Volbella
A collection of fillers – made for different needs
JUVÉDERM® is the #1 selling collection of hyaluronic acid fillers in the US. Each product in the JUVÉDERM® collection of fillers adds volume to a different area of the face to lift cheeks, smooth parentheses lines, or plump the lips. The results are subtle and long-lasting.
JUVÉDERM VOLBELLA® XC
injectable gel is for injection into the lips for lip augmentation and for correction of perioral rhytids in adults over the age of 21. A leading global pharmaceutical company, today announced that the company has received approval from the U.S. Food and Drug Administration (FDA) to market JUVÉDERM VOLBELLA® XC, for use in the lips for lip augmentation and for correction of perioral rhytids, commonly referred to as perioral lines, in adults over the age of 21.
In clinical trials, JUVÉDERM VOLBELLA® XC was found to effectively increase lip fullness and soften the appearance of lines around the mouth in a majority of subjects through one year.
JUVÉDERM VOLBELLA® XC was first approved in Europe in 2011. Currently, JUVÉDERM VOLBELLA® XC is distributed in more than 70 countries, including markets in Europe, Latin America, Middle East, Asia Pacific, and Canada.
The JUVÉDERM® family of products, including JUVÉDERM® Ultra XC and JUVÉDERM® Ultra Plus XC are marketed and sold in more than 80 countries outside the United States.
The JUVÉDERM® lip collection: two formulations for your unique needs.
- JUVÉDERM® Ultra XC adds fullness to lips.
- JUVÉDERM VOLBELLA® XC adds subtle volume to lips and softens the appearance of vertical lip lines.
JUVÉDERM VOLBELLA® XC is tailored to add subtle volume to the lips and smooth the appearance of vertical lip lines.
80% (98/123) of people treated experienced improved satisfaction with their lips 1 year later.
75% (92/123) of people treated experienced improved satisfaction with their vertical lip lines 1 year later.
When treated again after 1 year, patients needed less product to achieve their results.